nicotinamide mononucleotide has been researched along with Pancreatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Geng, XL; Li, GQ; Li, L; Li, ZB; Liu, LW; Lu, TQ; Shang, LR; Sui, YH; Sun, B; Wang, YW; Xie, Y; Xue, DB; Yang, WB; Zhang, T; Zhang, YY; Zhao, ZJ | 1 |
| Bao, J; Chen, C; Dai, J; He, Y; Hu, G; Husain, SZ; Jiang, M; Li, B; Li, L; Niu, M; Wen, L; Wu, Z; Zhang, X | 1 |
2 other study(ies) available for nicotinamide mononucleotide and Pancreatitis
| Article | Year |
|---|---|
Gut microbiota-derived nicotinamide mononucleotide alleviates acute pancreatitis by activating pancreatic SIRT3 signalling.
Topics: Acute Disease; Animals; Ceruletide; Dysbiosis; Gastrointestinal Microbiome; Inflammation; Mice; NAD; Nicotinamide Mononucleotide; Pancreatitis; Rats; Sirtuin 3 | 2023 |
Inhibition of nicotinamide phosphoribosyltransferase protects against acute pancreatitis via modulating macrophage polarization and its related metabolites.
Topics: Acute Disease; Animals; Ceruletide; Cytokines; Macrophages; Mice; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Pancreatitis; Sirtuin 1 | 2021 |